Drug Development Market Research Reports & Industry Analysis
The drug development industry is dedicated to creating and refining treatments that improve lives and combat diseases. This field is in a state of rapid transformation, driven by advances in technology, regulatory changes, and shifting patient needs. MarketResearch.com provides hundreds of drug development industry reports to allow stakeholders to understand important market trends, challenges, and opportunities with unparalleled clarity.
Drug Development Market Research and Industry Forecasts
- Our wide-ranging reports cover a variety of dynamic markets and provide drug development market size and growth forecasts.
- Additionally, our research includes pipeline assessments of clinical trial products and clinical developments, value chain analysis, price indicators, and more.
- The competitive landscape is also covered in detail, with information on market structure, key players, company overviews, product portfolios, financials, and SWOT analyses.
MarketResearch.com: Your Dedicated Partner
Designed with consultants and busy executives in mind, our reports are powerful tools for enhancing your decision-making process. Our research can help you anticipate market changes and seize emerging opportunities as the drug development industry continues to evolve. Browse our full list of drug development market research reports to get started.
Drug Development Industry Research & Market Reports
-
Global Drug Discovery Market Forecast 2022-2030
... the technological advancements are the primary factors propelling the market growth. MARKET INSIGHTS Drug discovery entails identifying the potential new medicines in a vast range of scientific disciplines like pharmacology, chemistry, and biology. The drug ... Read More
-
Digital Pathology Market by Product( ArtificiaI Intelligence, Scanner, Software, Storage), Type(Human, Veterinary), Application( Teleconsultation, Training, Disease Diagnosis, Drug Discovery), End User( Pharma, Academia, Hospitals ) - Global Forecast to 2026
... is projected to reach USD 1,371 million by 2026 from USD 736 million in 2021, at a CAGR of 13.2% during the forecast period. The growth in the digital pathology market is mainly driven by ... Read More
-
Europe Drug Discovery Market Forecast 2022-2030
... technologies, and increased R&D expenses influence market growth in the region. MARKET INSIGHTS Italy, Russia, France, Germany, the United Kingdom, Spain, Scandinavia, and Rest of Europe are analyzed for the Europe drug discovery market growth ... Read More
-
Asia-pacific Drug Discovery Market Forecast 2022-2030
... offer lucrative research and clinical trials opportunities for pharmaceuticals and CROs. MARKET INSIGHTS Taiwan, Japan, Australia & New Zealand, India, Singapore, Indonesia, South Korea, China, and Rest of Asia-Pacific are analyzed for the Asia-Pacific drug ... Read More
-
North America Drug Discovery Market Forecast 2022-2030
... growing prioritization of several therapeutic areas like rare diseases and women’s health. REGIONAL INSIGHTS The United States and Canada are assessed for the North America drug discovery market growth analysis. In Canada, the drug discovery ... Read More
-
Cell Line Development Market Size, Share and Industry Analysis Report by Product (Reagents & Media, Equipment {Incubator, Centrifuge, Bioreactor, Storage Equipment, Microscope, Electroporators, FACS}, Accessories & Consumables), by Source (Mammalian, Non-mammalian {Insects, Amphibians}), by Cell Line (Recombinant, Hybridomas, Continuous Cell Line, Primary Cell Line), by Application (Bioproduction, Drug Discovery, Toxicity Testing, Tissue Engineering, Research), Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2022 - 2028
... Line (Recombinant, Hybridomas, Continuous Cell Line, Primary Cell Line), by Application (Bioproduction, Drug Discovery, Toxicity Testing, Tissue Engineering, Research), Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2022 - 2028 The cell line development ... Read More
-
Global Live Cell Encapsulation Market Size study, By Manufacturing Technique (Simple Dripping, Electrostatic Dripping, Liquid Jet Break Up, Coaxial Airflow, Vibrating Jet, Jet Cutting, Rotating Disk Atomization), By Polymer Type (Alginate, HEMA-MMA, Chitosan, Siliceous Encapsulates, Cellulose Sulfate, PAN-PVC, Other Polymers), By Application (Drug Delivery, Regenerative medicine, Cell Transplantation, Probiotics, Research), and Regional Forecasts 2022-2028
... Cellulose Sulfate, PAN-PVC, Other Polymers), By Application (Drug Delivery, Regenerative medicine, Cell Transplantation, Probiotics, Research), and Regional Forecasts 2022-2028Global Live Cell Encapsulation Market is valued approximately USD 266.26 million in 2021 and is anticipated to ... Read More
-
Recombinant Proteins Market Size, Share & Trends Analysis By Product, By Application, By End-User, Regional Outlook, Competitive Strategies and Segment Forecasts to 2030
... 2030. According to SPER Market Research, the recombinant proteins market estimated to reach USD 2.4 billion by 2030 with a CAGR of 10.2%. The fuels for the escalation of the market are; the collaboration of ... Read More
-
Cell-based Assays Market Size, Share & Trends Analysis By Product & Service, By Type, By End User, Regional Outlook, Competitive Strategies and Segment Forecasts to 2030
... USD 30.4 billion by 2030 According to SPER Market Research, the cell-based assays market is estimated to reach USD 30.4 billion by 2030 with a CAGR of 7.4%. Rising prevalence of infectious diseases and risk ... Read More
-
2022 Global: Immunotherapy Drugs - Innovative Markets Forecast (2028) report
... 2028. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2017 to 2028 using regression analysis in ... Read More
-
Europe Genome Editing Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (CRISPR, TALEN, Antisense, and Other), Application (Cell Line Engineering, Genetic Engineering, Diagnostic Applications, Drug Discovery, and Others), and End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Clinical Research Organizations)
... (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Clinical Research Organizations) The genome editing market in Europe is expected to grow from US$ 1,487.30 million in 2021 to US$ 4,791.46 million by 2028; it ... Read More
-
Middle East and Africa Genome Editing Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (CRISPR, TALEN, Antisense, and Other), Application (Cell Line Engineering, Genetic Engineering, Diagnostic Applications, Drug Discovery, and Others), and End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Clinical Research Organizations)
... and End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Clinical Research Organizations) The genome editing market in the Middle East & Africa is expected to grow from US$ 205.01 million in 2021 ... Read More
-
North America Genome Editing Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (CRISPR, TALEN, Antisense, and Other), Application (Cell Line Engineering, Genetic Engineering, Diagnostic Applications, Drug Discovery, and Others), and End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Clinical Research Organizations)
... User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Clinical Research Organizations) The genome editing market in North America is expected to grow from US$ 2,136.41 million in 2021 to US$ 7,024.71 million by ... Read More
-
South America Genome Editing Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (CRISPR, TALEN, Antisense, and Other), Application (Cell Line Engineering, Genetic Engineering, Diagnostic Applications, Drug Discovery, and Others), and End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Clinical Research Organizations)
... User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Clinical Research Organizations) The genome editing market in South America is expected to grow from US$ 319.10 million in 2021 to US$ 1,003.03 million by ... Read More
-
Asia Pacific Genome Editing Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (CRISPR, TALEN, Antisense, and Other), Application (Cell Line Engineering, Genetic Engineering, Diagnostic Applications, Drug Discovery, and Others), and End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Clinical Research Organizations)
... User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Clinical Research Organizations) The genome editing market in Asia Pacific is expected to grow from US$ 1,051.58 million in 2021 to US$ 3,557.63 million by ... Read More
-
Coronavirus Disease 2019 (COVID-19) Clinical and Commercial Analyzer - March 2022
... interventions to curb these potential disasters. The COVID-19 Clinical and Commercial Analyzer is an interactive Excel-based tool that scores leading pipeline-stage vaccines and therapeutics on a range of clinical and commercial parameters based on available ... Read More
-
Metabolomics Market by Product and Service (Metabolomics Instruments and Metabolomics Bioinformatics Tools & Service), Application (Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics, Personalized Medicine, and Others), and Indication (Cancer, Cardiovascular Disorders, Neurological Disorders, Inborn Errors of Metabolism, and Others): Global Opportunity Analysis and Industry Forecast, 2021––2030
... Inborn Errors of Metabolism, and Others): Global Opportunity Analysis and Industry Forecast, 2021––2030 Metabolomics is study and analysis of biochemical processes involving intermediates and products of metabolic activity. The products are called as metabolomes that ... Read More
-
Gastroparesis Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2021-2026
... 90% molecules present in early stage. Mid-sized Pharma dominates R&D in this indication. The rising prevalence and more frequent use of newer symptomatic treatments are expected to drive the market. However, the market growth is ... Read More
-
Healthcare Artificial Intelligence (AI) Market Forecasts to 2028 – Global Analysis By Technology (Deep Learning, Machine), Application (Drug Discovery, Fraud Detection), End User (Research Laboratories, Hospital) and By Geography
... Healthcare Artificial Intelligence (AI) Market is accounted for $6.66 billion in 2021 and is expected to reach $86.37 billion by 2028 growing at a CAGR of 44.2% during the forecast period. Artificial intelligence was initiated ... Read More
-
iPSC derived NK cells - Pipeline Insight, 2022
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • ... Read More
-
Fatigue Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Fatigue (Central Nervous System) pipeline landscape. Fatigue also referred to as tiredness, exhaustion, lethargy, listlessness, and describes a physical and/or mental state ... Read More
-
Histone Deacetylase 8 (Histone Deacetylase Like 1 or HDAC8 or EC 3.5.1.98) Drugs In Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Deacetylase Like 1 or HDAC8 or EC 3.5.1.98) - Histone deacetylase 8 is an enzyme encoded by the HDAC8 gene. It is responsible for the deacetylation of lysine residues on the N-terminal part of the ... Read More
-
Left Ventricular Dysfunction Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Left Ventricular Dysfunction (Cardiovascular) pipeline landscape. Left ventricular dysfunction is the most common cause of congestive heart failure. ... Read More
-
Restless Legs Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Restless Legs Syndrome (Central Nervous System) pipeline landscape. Restless legs syndrome (RLS), also known as Willis-Ekbom disease (WED), ... Read More
-
Fibromyalgia (Fibromyalgia Syndrome) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Fibromyalgia (Central Nervous System) pipeline landscape. Fibromyalgia is a disorder characterized by widespread musculoskeletal pain accompanied by fatigue, ... Read More
Research Assistance
